A carregar...
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature
Background: Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in different cancer types. Tumor type agnostic therapy is based on targetin...
Na minha lista:
| Publicado no: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920250/ https://ncbi.nlm.nih.gov/pubmed/33669326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14020159 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|